Form 8-K - Current report:
SEC Accession No. 0001193125-21-092693
Filing Date
2021-03-24
Accepted
2021-03-24 16:37:02
Documents
3
Period of Report
2021-03-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d119670d8k.htm 8-K 18770
2 EX-99.1 d119670dex991.htm EX-99.1 46505
3 GRAPHIC g119670logo.jpg GRAPHIC 4351
  Complete submission text file 0001193125-21-092693.txt   72714
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39244 | Film No.: 21768580
SIC: 2834 Pharmaceutical Preparations